Library · 26 compounds

The compound library.

What each compound is, what the evidence actually says, and the risks. Educational information only — this is not a recommendation to use anything.

BPC-157

Healing & recovery peptide

NOT FDA APPROVED

A synthetic peptide derived from a protein found in gastric juice. Proposed to promote angiogenesis (new blood-vessel growth) and tissue repair. Its mechanism in humans is not well established.

Read profile →

TB-500

Healing & recovery peptide

NOT FDA APPROVED

A synthetic fragment related to Thymosin Beta-4, a protein involved in cell migration and repair. Proposed to support tissue regeneration and reduce inflammation.

Read profile →

GHK-Cu

Cosmetic copper peptide

NOT FDA APPROVED

A naturally occurring copper-binding peptide. In skin it is associated with collagen support, wound signalling, and antioxidant activity.

Read profile →

Semaglutide

GLP-1 receptor agonist

FDA APPROVED · RX

Mimics the GLP-1 hormone: it increases insulin secretion when blood sugar is high, slows stomach emptying, and reduces appetite.

Read profile →

Tirzepatide

GIP / GLP-1 dual agonist

FDA APPROVED · RX

Activates two gut-hormone receptors (GIP and GLP-1) to improve insulin response, slow gastric emptying, and reduce appetite.

Read profile →

Retatrutide

GLP-1 / GIP / glucagon triple agonist

INVESTIGATIONAL

Activates three receptors (GLP-1, GIP and glucagon), which may increase energy expenditure on top of appetite reduction.

Read profile →

Liraglutide

GLP-1 receptor agonist

FDA APPROVED · RX

A GLP-1 receptor agonist, the earlier-generation version of the mechanism used by semaglutide.

Read profile →

Cagrilintide

Long-acting amylin analog

INVESTIGATIONAL

Mimics amylin, a hormone that promotes satiety, complementing GLP-1 mechanisms.

Read profile →

AOD-9604

Metabolic / fat-loss peptide

NOT FDA APPROVED

A modified fragment of the hGH molecule proposed to stimulate fat breakdown (lipolysis) without the growth-hormone effects on IGF-1 or blood sugar.

Read profile →

Ipamorelin

Growth-hormone secretagogue

NOT FDA APPROVED

A ghrelin-receptor agonist that prompts the pituitary to release a pulse of growth hormone, in a relatively selective way.

Read profile →

CJC-1295

Growth-hormone-releasing hormone analog

NOT FDA APPROVED

A GHRH analog that stimulates the pituitary to release growth hormone. The DAC version binds albumin to extend its action.

Read profile →

Sermorelin

Growth-hormone-releasing hormone analog

NOT FDA APPROVED

A GHRH analog. It stimulates natural, pulsatile GH release rather than replacing GH directly.

Read profile →

Tesamorelin

Growth-hormone-releasing hormone analog

FDA APPROVED · RX

A stabilised GHRH analog that stimulates growth-hormone release, which in trials reduced visceral fat.

Read profile →

MK-677 (Ibutamoren)

Growth-hormone secretagogue (non-peptide)

NOT FDA APPROVED

A non-peptide ghrelin-receptor agonist that produces sustained (non-pulsatile) GH and IGF-1 elevation across 24 hours.

Read profile →

Hexarelin

Growth-hormone secretagogue

NOT FDA APPROVED

A potent GH-releasing peptide (GHRP) acting on the ghrelin receptor.

Read profile →

PT-141 (Bremelanotide)

Melanocortin receptor agonist

FDA APPROVED · RX

Activates melanocortin receptors in the brain, influencing sexual desire and arousal centrally rather than through blood flow.

Read profile →

Melanotan II

Melanocortin receptor agonist (tanning)

NOT FDA APPROVED

A non-selective melanocortin agonist that stimulates melanin production (tanning) and also acts on desire and appetite pathways.

Read profile →

Afamelanotide (Melanotan I)

Melanocortin receptor agonist

FDA APPROVED · RX

A selective melanocortin-1 receptor agonist that increases eumelanin, providing photoprotection.

Read profile →

Semax

Cognitive / neuroprotective peptide

NOT FDA APPROVED

A synthetic ACTH fragment analog proposed to modulate BDNF and neuroprotective pathways.

Read profile →

Selank

Cognitive / anxiolytic peptide

NOT FDA APPROVED

A synthetic analog of the immunomodulatory peptide tuftsin, proposed to influence GABA and serotonin systems.

Read profile →

SS-31 (Elamipretide)

Mitochondrial-targeted peptide

FDA APPROVED · RX

A peptide that concentrates in mitochondria and stabilises cardiolipin, improving mitochondrial function and reducing oxidative stress.

Read profile →

MOTS-c

Mitochondrial-derived peptide

NOT FDA APPROVED

A peptide encoded in mitochondrial DNA that influences metabolism and insulin sensitivity; studied as an exercise-mimetic.

Read profile →

Epithalon

Longevity peptide

NOT FDA APPROVED

A short synthetic peptide claimed to activate telomerase and influence the pineal gland and circadian regulation.

Read profile →

5-Amino-1MQ

Metabolic research compound

NOT FDA APPROVED

Inhibits the enzyme NNMT, which in animal studies is linked to fat metabolism and cellular energy handling.

Read profile →

Thymosin Alpha-1

Immune-modulating peptide

NOT FDA APPROVED

A naturally occurring thymic peptide that modulates T-cell and innate immune function.

Read profile →

DSIP

Sleep peptide

NOT FDA APPROVED

A naturally occurring peptide historically associated with sleep regulation, though its role is not well defined.

Read profile →